References
(in the order to which they are referred on this site)
- Overdevest, J.B., Theodorescu, D., and Lee, J.K (2009). Utilizing the Molecular Gateway: The Path to Personalized Cancer Management. Clinical Chemistry 55:4, 684-697.
- Paegal, B.M., Blazej, R.G., and Mathies, R.A. (2003). Microfluidic devices for DNA sequencing: sample preparation and electrophoretic analysis. Current Opinions in Biotechnology 14:1, 42-50.
- Blazej, R.G., Kumaresan,P., Cronier,S.A., and Mathies, R.A (2007). Inline Injection Microdevice for Attomole-Scale Sanger DNA Sequencing. Analytical Chemistry 79:12, 4499-4506.
- Dempke, W.C.M., Suto, T., and Reck, M (2010). Targeted therapies for non-small cell lung cancer. Lung Cancer 67, 257-274.
- Printz, C (2010). Physicians Optimistic About Advances in Lung Cancer and Melanoma Treatment. Cancer 116:10, 2287-2288.
- Heist, R.S. and Christiani, D (2009). EGFR-targeted therapies in lung cancer: predictors of response and toxicity. Pharmacogenomics 10:1, 59-68.
- Ponder, B. (1997). Genetic Testing for Cancer Risk. Science 278:5340, 1050-1054.
- Jorgensen, J.T., Nielsen, K.V., and Ejlertson, B. (2007). Pharmacodiagnostics and Targeted Therapies- A Rational Approach for Individualizing Medical Anticancer Therapy in Breast Cancer. The Oncologist 12, 397-405.
Links
- Oncomine - Transcriptome profile database
- International HapMap Project - an international effort to compile publications and data related to haplotype mapping
- Illumina, Inc.- high throughput genetic sequencing
- Roche 454 Sequencing- high throughput genetic sequencing
- COSMIC- the Catalogue of Somatic Mutations in Cancer